In a series of phase 3 trials (LEAD trials), liraglutide was shown to be more effective in reducing HbA1c by 1.2 to 1.6% when used either as monotherapy or in combination with other diabetes drugs, whilst conferring weight loss of 23 kg, an effect which is especially favourable in comparison to the weight gain associated with insulin glargine or sulphonylurea treatment [18]
Krutermax verbindet seit 1890 traditionelles Kruterwissen mit moderner Fachberatung und sorgfltiger Produktauswahl
Health insurance plans often deny coverage for drugs used off-label
Depending on the patients response to treatment and their tolerance, the dose can be further increased: 7.5 mg once weekly (after at least 4 weeks on 5 mg)
Renoprotective effect of scutellarin on cisplatin-induced renal injury in mice: Impact on inflammation, apoptosis, and autophagy
Combined with developments like oral GLP-1s , that could mean a future with millions more people taking them for entirely different reasons